Monoclonal Antibody Treatment Available

UP Health System - Portage is proud to offer monoclonal antibody treatment to help treat non-hospitalized patients with mild or moderate cases of COVID-19. Patients who receive this treatment must meet specific clinical criteria. 

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful viruses. These intravenous (IV) treatments help lessen the severity of the virus in individuals who are COVID-19-positive and are at risk for developing a severe form of the disease. Patients receiving treatment at our hospital will be required to stay for a duration of 2 hours: 1 hour for treatment followed by a 1-hour observation.

This innovative treatment is designed to help lessen the severity of COVID-19 in individuals who are COVID-19-positive and are at risk for developing a severe form of the disease. Overall, it has proven to decrease hospitalizations in the higher-risk population that has received the therapy.

"Our team has seen promising results in our initial patients,” said Keith Wright, DO, Internal Medicine. “Offering this treatment locally is an important step forward in helping prevent the most at-risk patients from being hospitalized due to COVID-19." 

Patients (age 12 and up) must meet specific clinical criteria, including having a lab-confirmed case of COVID-19 that is mild or moderate, and:

  • Less than 10 days since the start of symptoms;
  • Stable enough to not need hospitalization;
  • Underlying medical conditions; other medical conditions or other criteria as determined by your provider.
  • An order from a provider.

For additional information on treatment for COVID-19 at UP Health System - Portage, please call 906.483.1574.